Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Small Molecules in Development for the Treatment of Spinal Muscular Atrophy.
- Alyssa N Calder, E. Androphy, K. Hodgetts
- Chemistry, Medicine
- Journal of medicinal chemistry
- 1 August 2016
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease resulting from pathologically low levels of survival motor neuron (SMN) protein. The majority of mRNA from the SMN2… Expand
Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease
- K. Takahashi, Qiongman Kong, +11 authors C. G. Lin
- Medicine, Biology
- The Journal of experimental medicine
- 9 March 2015
Takahashi et al. demonstrate that restoring glial glutamate transporter EAAT2 function improves cognitive functions and synaptic integrity while reducing amyloid plaques in a sustained fashion after… Expand
trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents.
- X. Zhang, K. Hodgetts, +10 authors A. Thurkauf
- Medicine, Chemistry
- Journal of medicinal chemistry
- 30 September 2000
The dopaminergic receptor profile of a series of trans-1-[(2-phenylcyclopropyl)methyl]-4-arylpiperazines was examined. Aromatic substitution patterns were varied with the goal of identifying a… Expand
Primary epineural repair of the ulnar nerve in children.
- D. G. Bolitho, M. Boustred, D. Hudson, K. Hodgetts
- Medicine
- The Journal of hand surgery
- 1999
Transectional nerve injuries are uncommon in children. We report the outcome of 19 children aged < or = 13 years with acute transectional injuries to the ulnar nerves who were treated by primary… Expand
The Role of Fluorine in the Discovery and Optimization of CNS Agents: Modulation of Drug-Like Properties
- K. Hodgetts, K. Combs, A. Elder, G. Harriman
- Chemistry
- 2010
Publisher Summary This chapter highlights the role of fluorine in the discovery and optimization of central nervous system (CNS) agents. It also describes the strategic placement of fluorine into… Expand
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor…
- K. Hodgetts, Ping Ge, +12 authors D. Doller
- Chemistry, Medicine
- Journal of medicinal chemistry
- 27 May 2011
The design, synthesis, and structure-activity relationships of a novel series of pyrazines, acting as corticotropin releasing factor-1 (CRF-1) receptor antagonists, are described. Synthetic… Expand
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy.
- A. Rietz, H. Li, +14 authors K. Hodgetts
- Chemistry, Medicine
- Journal of medicinal chemistry
- 19 May 2017
Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. We previously developed a high-throughput assay that employs an SMN2-luciferase reporter allowing identification of… Expand
A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice
- S. Nuber, Alice Y Nam, +13 authors D. Selkoe
- Chemistry, Medicine
- Annals of neurology
- 29 September 2020
Parkinson disease (PD) has useful symptomatic treatments that do not slow the neurodegenerative process, and no significant disease‐modifying treatments are approved. A key therapeutic target in PD… Expand
Primary Epineural Repair of the Median Nerve in Children
- D. Hudson, D. G. Bolitho, K. Hodgetts
- Medicine
- 1 February 1997
We report 18 children (12 boys and six girls) with a mean age of 6.1 years who sustained lacerations of the median nerve. Associated injuries to other structures occurred in 15 children. Treatment… Expand
From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonist.
- X. Zheng, K. Hodgetts, +11 authors C. Blum
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 1 October 2006
Bioisosteric replacement of piperazine with an aryl ring in lead VR1 antagonist 1 led to the biarylamide series. The development of B-ring SAR led to the conformationally constrained analog 70. The… Expand